Palliative care in the last days of life — anticipatory prescribing & syringe driver (CSCI; care of the dying adult)
Bedside summary
Recognising dying and providing proactive symptom control in the last days of life. Core elements: recognise irreversible dying and agree goals with patient/family; stop non-essential interventions and medicines; prescribe individualised anticipatory ('just in case') subcutaneous medicines for the 5 common terminal symptoms (pain, breathlessness, nausea/vomiting, respiratory secretions, agitation/restlessness); and start a continuous subcutaneous infusion (syringe driver / CSCI) when more than 2-3 as-required doses are needed in 24 hours. Doses below are starting-dose guides for an opioid-naive adult with normal renal function — verify against local formulary and reduce in frailty/renal impairment.
Red flags
- A potentially reversible cause of deterioration that the patient would want treated (sepsis, hypercalcaemia, opioid toxicity, obstruction) — do not mislabel as dying
- Opioid toxicity mistaken for terminal agitation (myoclonus, pinpoint pupils) — reduce/rotate opioid, consider renal impairment
- Terminal agitation due to urinary retention or faecal impaction — relieve mechanically before sedating
- Family/carer distress or disagreement about recognising dying — needs clear communication, not just prescribing
- Haemorrhage, major seizure or acute severe breathlessness — crisis anticipatory plan (midazolam, opioid) should be in place
Assessment
Differential diagnosis
- Confirm dying is irreversible vs a reversible deterioration (infection, hypercalcaemia, AKI, opioid toxicity, delirium cause, obstruction) that the patient would want treated
- Distinguish terminal agitation from reversible causes: urinary retention, constipation/impaction, pain, hypoxia, drug toxicity, nicotine/alcohol/benzodiazepine withdrawal
- Distinguish respiratory secretions (death rattle) from pulmonary oedema/infection
Investigations
- Clinical recognition of dying (multidisciplinary) — generally no new investigations in the actively dying
- Review and rationalise medicines; convert essential oral drugs to SC route
- Check for and treat reversible contributors ONLY if consistent with goals (e.g. catheterise for retention, treat hypercalcaemia if appropriate)
- Document ReSPECT/DNACPR, preferred place of care/death, and communicate plan with family
Management
- Recognise and sensitively communicate that the person is dying; agree an individualised care plan with patient (if able) and those important to them
- Review all medications: stop non-essential drugs (statins, antihypertensives, oral hypoglycaemics, bisphosphonates); continue/convert essential symptom-control drugs to subcutaneous route
- Prescribe anticipatory SC medicines PRN for all 5 symptoms so there is no delay: analgesic (opioid), antiemetic, sedative/anxiolytic (midazolam), antisecretory, and ensure water for injection
- Ensure attention to mouth care, pressure-area care, continence, positioning, and psychological/spiritual/family support
- If >2-3 PRN doses needed in 24 h, or oral route lost, start a continuous subcutaneous infusion (CSCI/syringe driver) over 24 h; add the total PRN used to the background
- For pain in an opioid-naive patient: use PRN morphine; if already on oral opioid, convert to SC equivalent (oral morphine to SC morphine divide by 2) for the driver, with breakthrough = 1/6 of 24-h SC dose
- For secretions: reposition; start an antimuscarinic early (effect is on NEW secretions); reassure family it is usually not distressing to the patient
- For terminal agitation/restlessness: exclude reversible causes (retention, pain, impaction), then midazolam PRN/CSCI; add levomepromazine or haloperidol if delirium/agitation persists
- Review at least daily (or more often); titrate; check syringe-driver site and drug compatibility
Drugs & doses
Disposition
Complications & pitfalls
- Uncontrolled symptoms from under-prescribing or delayed syringe driver
- Over-sedation / opioid toxicity from conversion error or renal impairment
- Syringe-driver drug incompatibility/precipitation, site reactions
- Family distress, complicated grief if communication poor; moral/legal concern if dying mislabelled (Gosport learning)
Exam pearls
- Guidance: NICE NG31 (care of dying adults in the last days of life); Palliative Care Formulary; Scottish Palliative Care Guidelines.
- Anticipatory prescribing = prescribe all 5 symptom drugs 'just in case' so there is never a delay reaching medication at home or on the ward.
- Start a syringe driver if more than 2-3 PRN doses are needed in 24 h, or the oral route is lost.
- Antisecretory drugs only prevent NEW secretions — start early and manage family expectations; death rattle rarely distresses the patient.
- Always exclude retention, impaction, pain and opioid toxicity before attributing agitation to 'terminal restlessness'.
- Hyoscine butylbromide and glycopyrronium do not cross the blood-brain barrier (less sedation) and are preferred over hyoscine hydrobromide; cyclizine is incompatible with hyoscine butylbromide in a driver.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.